Jim contends that by virtue of being an investment strategist and a healthcare entrepreneur for 25 years, he was able to found Foresite Capital. He posits that after looking for key success factors, he found that most successful companies and entrepreneurs focus on innovation and teams. Jim says that he saw an opportunity to supply emerging healthcare companies with information, capital and networks to enable them to enhance their success.
Today, Foresite Capital has invested in corporations engaged in genomic sequencing and diagnostics, medical services, and biopharmaceuticals. Some of the notable companies that Foresite has invested in include Aimmune Therapeutics, Aerie Pharmaceuticals, Intarcia Therapeutics and 10x Genomics.
He spends much of his day working with members of his team in meetings and making calls. He networks with thought leaders in the healthcare industry as well as presenting new ideas and updating on the existing company portfolio. Jim notes that his favorite activity is having dinner with his family. In addition, between meetings, the shrewd entrepreneur finds time to work out. To Jim Tananbaum, the aspect of bringing ideas to life requires capital and engaging effective, persistent and smart thought leaders in the healthcare industry. He seeks to enable various companies to be in a position to undertake critical scientific discoveries that can be beneficial in the industry.
Jim contends that healthcare innovation excites him. He is optimistic that in the near future, people will have their saliva, blood or tissue sequenced for purposes of diagnosing diseases, thus preventing and treating them in time. Jim Tananbaum says that different companies have developed innovative applications in genomic sequencing and manufacture of drugs.
About Jim Tananbaum
The chief executive officer of Foresite Capital, a private healthcare equity firm, is a graduate of Yale University, Massachusetts Institute of Technology and Harvard University. Over the years, he has been passionate about marrying computer science and hard sciences with healthcare. He posits that because of having a broad network, he was honored to be mentored by renowned personalities. They include George Whitesides of Harvard University, Bob Gunderson of Gunderson Detmer, Roy Vagelos of Merck and Theravance, Rick Levin of Yale University and Rick Klausner of NCI. Visit his About.me page to know more.
Jim is credited for being one of the partners who founded Prospect Venture Partners II and III. He is also one of the partners of Sierra Ventures. Tananbaum has rendered his services for Jazz Pharmaceuticals, Healtheon, Amerigourp and Amira Pharmaceuticals.
See more: https://ideamensch.com/jim-tananbaum/